JP2021514011A5 - - Google Patents
Info
- Publication number
- JP2021514011A5 JP2021514011A5 JP2020566549A JP2020566549A JP2021514011A5 JP 2021514011 A5 JP2021514011 A5 JP 2021514011A5 JP 2020566549 A JP2020566549 A JP 2020566549A JP 2020566549 A JP2020566549 A JP 2020566549A JP 2021514011 A5 JP2021514011 A5 JP 2021514011A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- membered
- heteroaryl
- heteroatoms selected
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862632806P | 2018-02-20 | 2018-02-20 | |
| US62/632,806 | 2018-02-20 | ||
| US201862744083P | 2018-10-10 | 2018-10-10 | |
| US62/744,083 | 2018-10-10 | ||
| PCT/US2019/018774 WO2019164949A1 (en) | 2018-02-20 | 2019-02-20 | Pharmaceutical combinations of egfr inhibitors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021514011A JP2021514011A (ja) | 2021-06-03 |
| JP2021514011A5 true JP2021514011A5 (cg-RX-API-DMAC7.html) | 2022-02-25 |
Family
ID=67688573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566549A Pending JP2021514011A (ja) | 2018-02-20 | 2019-02-20 | Egfr阻害剤の組合せ医薬製剤およびその使用法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210085688A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3755337A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021514011A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019225807A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3087797A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019164949A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021514011A (ja) * | 2018-02-20 | 2021-06-03 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | Egfr阻害剤の組合せ医薬製剤およびその使用法 |
| CA3087716A1 (en) | 2018-02-20 | 2019-08-29 | Dana-Farber Cancer Institute, Inc. | Inhibitors of egfr and methods of use thereof |
| AU2019225799A1 (en) * | 2018-02-20 | 2020-07-09 | Dana-Farber Cancer Institute, Inc. | Pharmaceutical combinations of EGFR inhibitors and methods of use thereof |
| CN114553638A (zh) | 2018-09-15 | 2022-05-27 | 华为技术有限公司 | 一种通信方法、设备和系统 |
| US20240166665A1 (en) * | 2021-03-02 | 2024-05-23 | Dana-Farber Cancer Institute, Inc. | Covalent egfr inhibitors and methods of use thereof |
| EP4495119A4 (en) * | 2022-03-16 | 2025-06-25 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | FUSED HETEROCYCLIC COMPOUND, PREPARATION METHOD AND MEDICAL USE THEREOF |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070105835A1 (en) * | 2005-11-07 | 2007-05-10 | Kazantsev Aleksey G | Compositions and methods for modulating poly(ADP-ribose) polymerase activity |
| RU2016116516A (ru) * | 2008-12-08 | 2018-12-07 | Мандифарма Интернэшнл Корпорейшн Лимитед | Композиции ингибиторов тирозинкиназных рецепторов белков |
| DK3686193T3 (da) * | 2011-07-27 | 2022-05-30 | Astrazeneca Ab | 2-(2,4,5-substitueret anilino)pyrimidinforbindelser |
| WO2014160430A1 (en) * | 2013-03-13 | 2014-10-02 | Georgetown University | Small molecule lrrk2 and erk5 inhibitors |
| US20170114323A1 (en) * | 2014-06-19 | 2017-04-27 | Whitehead Institute For Biomedical Research | Uses of kinase inhibitors for inducing and maintaining pluripotency |
| WO2017120429A1 (en) * | 2016-01-07 | 2017-07-13 | CS Pharmasciences, Inc. | Selective inhibitors of clinically important mutants of the egfr tyrosine kinase |
| AU2017248186B2 (en) * | 2016-04-07 | 2021-10-21 | Dana-Farber Cancer Institute, Inc. | Pyrimido-diazepinone kinase scaffold compounds and methods of treating PI3K-mediated disorders |
| WO2019164932A1 (en) * | 2018-02-20 | 2019-08-29 | Dana-Farber Cancer Institute, Inc. | Degraders of egfr and methods of use thereof |
| JP2021514011A (ja) * | 2018-02-20 | 2021-06-03 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | Egfr阻害剤の組合せ医薬製剤およびその使用法 |
| CA3087716A1 (en) * | 2018-02-20 | 2019-08-29 | Dana-Farber Cancer Institute, Inc. | Inhibitors of egfr and methods of use thereof |
| EP3755697A4 (en) * | 2018-02-20 | 2021-10-27 | Dana-Farber Cancer Institute, Inc. | EGFR DEGRADATION AGENTS AND METHODS FOR USING THEM |
-
2019
- 2019-02-20 JP JP2020566549A patent/JP2021514011A/ja active Pending
- 2019-02-20 EP EP19757001.3A patent/EP3755337A4/en not_active Withdrawn
- 2019-02-20 WO PCT/US2019/018774 patent/WO2019164949A1/en not_active Ceased
- 2019-02-20 AU AU2019225807A patent/AU2019225807A1/en not_active Abandoned
- 2019-02-20 US US16/970,860 patent/US20210085688A1/en not_active Abandoned
- 2019-02-20 CA CA3087797A patent/CA3087797A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514400A5 (cg-RX-API-DMAC7.html) | ||
| AU2019283921B2 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| CA2860951C (en) | Imidazopyrrolidinone compounds | |
| JP6401773B2 (ja) | Betブロモドメイン阻害剤およびこれを用いる治療方法 | |
| RU2481346C2 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
| RU2015106787A (ru) | Замещенные пирролы, активные в качестве ингибиторов киназ | |
| RU2015148189A (ru) | ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1 | |
| RU2008129810A (ru) | Противовирусные соединения | |
| MXPA04008680A (es) | Derivados de pirazol triciclicos, procedimientos para su preparacion y su uso como agentes anti-tumorales. | |
| JP2014503566A5 (cg-RX-API-DMAC7.html) | ||
| KR20170069199A (ko) | 섬유 아세포 성장 인자 수용체 키나아제 억제제인 인다졸계 화합물 및 이의 제조와 응용 | |
| RU2002129557A (ru) | Производные 8-хинолинксантина и 8-изохинолинксантина в качестве ингибиторов фосфоэстеразы pde5 | |
| JP2009543867A5 (cg-RX-API-DMAC7.html) | ||
| RU2012111215A (ru) | Гетероциклические соединения в качестве ингибиторов янускиназы | |
| JP2007521287A5 (cg-RX-API-DMAC7.html) | ||
| AR087336A1 (es) | Compuestos de 2-(2,4,5-anilino sustituido)pirimidina | |
| WO2005014572A1 (en) | Pyrimidylpyrrole derivatives active as kinase inhibitors | |
| RU2018102449A (ru) | Производные пиразоло[1,5-a]триазин-4-амина, применимые в терапии | |
| JP2021514398A5 (cg-RX-API-DMAC7.html) | ||
| JP2021518379A5 (cg-RX-API-DMAC7.html) | ||
| RU2006138606A (ru) | Ингибиторы киназы | |
| JP2021514399A5 (cg-RX-API-DMAC7.html) | ||
| CN103025722B (zh) | 具有2-(杂芳基)氨基取代基的氯苯吩嗪及其抗微生物活性 | |
| JP2003516994A5 (cg-RX-API-DMAC7.html) | ||
| US6815444B2 (en) | Anti-enterovirus compounds |